22
3
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T7660 |
IDO inhibitor 1
4-[[2-[(氨基磺酰基)氨基]乙基]氨基]-N'-(3-溴-4-氟苯基)-N-羟基-1,2,5-恶二唑-3-甲脒 |
Indoleamine 2,3-Dioxygenase (IDO) | Metabolism |
IDO inhibitor 1 是一种有效的吲哚胺-2,3 双加氧酶 (IDO) 抑制剂 (IC50 <100 nM)。具有潜在的免疫调节和抗肿瘤活性。 | |||
T3548 |
Epacadostat
INCB 024360,艾卡哚司他,IDO Inhibitor 1 |
IDO; Indoleamine 2,3-Dioxygenase (IDO) | Metabolism |
Epacadostat (INCB 024360) 是选择性的IDO1抑制剂,IC50=71.8 nM。 | |||
T4142 |
PCC0208009
IDO inhibitor 1,DO-IN-2,IDO-IN-2 |
Indoleamine 2,3-Dioxygenase (IDO) | Metabolism |
PCC0208009 (IDO-IN-2) 是一种有效的 IDO 抑制剂,其在 HeLa 细胞中的 IC50=4.52 nM。它调节 ACC 和杏仁核的突触可塑性,减少神经性疼痛和合并症。 | |||
T11901 |
IDO1-IN-5
|
IDO; Indoleamine 2,3-Dioxygenase (IDO) | Metabolism |
IDO1-IN-5 是可透过血脑屏障的、选择性的IDO1抑制剂,能够与缺乏血红素的 apo-IDO1 结合,但无法与成熟血红素的 IDO1 结合。 | |||
T7181 |
IDO-IN-1
4-氨基-N-(3-溴-4-氟苯基)-N'-羟基-1,2,5-恶二唑-3-甲脒 |
Indoleamine 2,3-Dioxygenase (IDO) | Metabolism |
IDO-IN-1 是吲哚胺-2,3-双加氧酶抑制剂,IC50=59 nM。 | |||
T20513 |
IDO1-IN-1
IDO1 inhibitor 1,2 HzBTZ,2-肼基苯并噻唑,IDO1IN1,2-HzBTZ,IDO1-inhibitor-1 |
IDO | Metabolism |
IDO1-IN-1 (2 HzBTZ) 是一种吲哚胺 2,3-双加氧酶 1 (IDO1) 抑制剂。 | |||
T1847 |
Necrostatin-1
Nec-1,Necrostatin 1 |
Indoleamine 2,3-Dioxygenase (IDO); Ferroptosis; Autophagy; RIP kinase | Apoptosis; Autophagy; Metabolism; NF-κB |
Necrostatin-1 (Nec-1) 是一种坏死性凋亡抑制剂和 RIP1 抑制剂,具有特异性。Necrostatin-1 抑制 TNF-α 诱导的坏死性凋亡。Necrostatin-1 也可以抑制 IDO。 | |||
T6543 |
Indoximod
NLG-8189,Indoximod (NLG-8189),1-Methyl-D-tryptophan,吲哚莫德 |
Indoleamine 2,3-Dioxygenase (IDO) | Metabolism |
Indoximod (Indoximod (NLG-8189)) 是一种具有口服具有活力的吲哚胺2,3-双加氧酶(IDO) 途径抑制剂。它在调节 mTOR 中充当 Trp 模拟物。它是一种可用于癌症研究的免疫代谢佐剂。 | |||
T11625 | IDO1 and HDAC1 Inhibitor | Others | Others |
IDO1 and HDAC1 Inhibitor is a dual IDO1 and HDAC1 inhibitor (IC50s: 69.0 nM and 66.5 nM). | |||
T7504 |
Necrostatin 2 racemate
5-[(7-氯-1H-吲哚-3-基)甲基]-3-甲基-2,4-咪唑烷二酮,Necrostatin-2 racemate |
RIP kinase | Apoptosis; NF-κB |
Necrostatin 2 racemate (Necrostatin-2 racemate) 是一种特异性的RIPK1抑制剂,是一种稳定型 Nec-1。 | |||
T4307 |
PF-06840003
EOS200271,PF 06840003 |
IDO; Indoleamine 2,3-Dioxygenase (IDO) | Metabolism |
PF-06840003 (EOS200271) 是口服具有活力的、选择性的IDO-1抑制剂,抑制 hIDO-1, dIDO-1和 mIDO-1 的IC50分别为 0.41 μM, 0.59 μM,和 1.5 μM。 | |||
T11616 |
IDO-IN-13
GS-4361 |
IDO; Indoleamine 2,3-Dioxygenase (IDO) | Metabolism |
IDO-IN-13 (GS-4361) 是 indoleamine 2,3-dioxygenase 1 抑制剂,EC50=17 nM。 | |||
T11619 |
IDO-IN-5
NLG-1489 |
IDO | Metabolism |
IDO-IN-5 is an indoleamine 2,3-dioxygenase (IDO) inhibitor (IC50: 1-10 μM). | |||
T11618 |
IDO-IN-4
|
Others | Others |
IDO-IN-4 is an indoleamine 2,3-dioxygenase 1 (IDO-1) inhibitor. | |||
T11621 |
IDO-IN-8
NLG-1487 |
IDO | Metabolism |
IDO-IN-8 is an indoleamine 2,3-dioxygenase (IDO) inhibitor (IC50: 1-10 μM). | |||
T11623 |
IDO/TDO-IN-1
|
Others | Others |
IDO/TDO-IN-1 is an orally active dual indoleamine-2,3-dioxygenase (IDO) and tryptophan 2,3-dioxygenase (TDO) inhibitor (IC50s: 9.7 and 47 nM). | |||
T39089 |
Acid secretion-IN-1
|
||
Acid secretion-IN-1, a polycyclic compound, is synthesized for its application as an IDO inhibitor in synthetic experiments. | |||
T79189 |
1-Isopropyltryptophan
1-IsoPT |
Indoleamine 2,3-Dioxygenase (IDO) | Metabolism |
1-Isopropyltryptophan (1-IsoPT)为IDO1抑制剂,能够抑制IFN-γ刺激下IDO-1与IDO-2 mRNA的表达水平。 | |||
T74536 | IDO/Tubulin-IN-2 | ||
IDO/Tubulin-IN-2 (HT2) 是一种对TDO和微管蛋白 (tubulin)展现出高效抑制作用的化合物。该抑制剂对多种癌细胞系(包括U87、HepG2、A549、HCT-116和LO2)均表现出强抗肿瘤活性,其半抑制浓度(IC50)分别为0.43、0.036、0.041、0.095和1.04 μM,有效提升了抗肿瘤效果。 | |||
T40211 |
eIF4E-IN-1
eIF4E-IN-1 |
||
eIF4E-IN-1 (WO2021003194A1, compound Y), is a highly effective inhibitor of eIF4E, a key protein involved in immunosuppression. By targeting immune checkpoint proteins such as PD-1, PD-L1, LAG3, TIM3, and IDO, eIF4E-IN-1 functions to disrupt immune suppression and promote immune release in specific diseases such as cancer and infectious diseases. | |||
T38276 |
Benzomalvin C
|
||
Benzomalvin C is a weak antagonist of the neurokinin-1 (NK1) receptor inhibiting binding of substance P by 46% when used at 100 μg/ml in vitro. It is also a weak inhibitor of indolamine 2,3-dioxygenase (IDO) with an IC50 value of 130 μM for recombinant IDO. It was isolated from Penicillium and contains an epoxide group at C-19 and C-20, which is not present in benzomalvins A, B, or E. | |||
T60266 |
(Rac)-Indoximod
|
||
(Rac)-Indoximod (1-Methyl-DL-tryptophan) is a potent inhibitor of indoleamine 2,3-dioxygenase (IDO). Combined treatment with IFN-γ and (Rac)-Indoximod significantly suppresses the activity of α-SMA-expressing human cardiac myofibroblasts (hCMs) and promotes apoptosis by up-regulating the genes IRF-1, Fas, and FasL. Moreover, this co-treatment effectively improves cardiac fibrosis[1]. |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T2718 |
Palmatine chloride
|
Others; Indoleamine 2,3-Dioxygenase (IDO); Aurora Kinase | Cell Cycle/Checkpoint; Chromatin/Epigenetic; Metabolism; Others |
Palmatine chloride 是口服具有活力的不可逆 IDO-1抑制剂。它能够减轻结肠损伤,预防肠道菌群失调和调节色氨酸分解代谢,并改善 DSS 诱发的结肠炎。 | |||
T5S0802 |
Palmatine
巴马汀,Berbericinine,Burasaine |
Indoleamine 2,3-Dioxygenase (IDO); AChR; AChE; Aurora Kinase | Cell Cycle/Checkpoint; Chromatin/Epigenetic; Metabolism; Neuroscience |
Palmatine (Burasaine) 是口服具有活力的、不可逆IDO-1抑制剂。它可以减轻结肠损伤,预防肠道菌群失调和调节色氨酸分解代谢,从而改善DSS (Dextran Sulphate Sodium Salt) 诱发的结肠炎。它有用于结肠炎的研究潜力。 | |||
T72508 | Palmatine hydroxide | ||
Palmatine hydroxide 是不可逆的口服活性IDO-1抑制剂,其对HEK 293-hIDO-1 和 rhIDO-1的IC50值分别为3 μM和157 μM。该化合物还能非竞争性抑制(WNV)NS2B-NS3蛋白酶,IC50值为96 μM。Palmatine hydroxide展现了抗癌、抗炎、神经保护、抗细菌和抗病毒的活性。 |